Beta, in-vivo CRISPR matlab liver mein hi genes ko theek karne ki nayi takneek. CDSCO ke paas pehla aavedan aaya hai, toh hum safety aur long-term asar ko bahut gaur se dekh rahe hain. Ye rare diseases ke liye umeed ki kiran ho sakti hai, par hamari zimmedari hai ki pehle trial mein bhi kisi bachche ko nuksaan na ho.
Meri maa ke ghutne ka dard jo physio se thik ho sakta tha, par usne mana kar diya — isliye main jaanta hun ki nayi dawa ka vishwas aur dar dono sath hote hain.
#exams#study
Jump in to reply — no account needed.